Companies collaborate at Danaher Life Sciences Biologics Day to present the latest technological developments for biopharmaceutical analysis

SCIEX features its ground-breaking biologics solutions including the X500B QTOF System and the Fast Glycan Labeling and Analysis Kit April 11, 2017 Framingham, MA — SCIEX, a Danaher company and global leader in life science analytical technologies, today announced that it presented the company’s latest ground-breaking biologics solutions at the Danaher Life Sciences Biologics Day.... Read more

Roka Bioscience to participate in the 40th Annual National Food Policy Conference

Roka Bioscience to participate in the 40th Annual National Food Policy Conference WARREN, N.J., April 10, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that Dr. Erin Dreyling, Vice President, Research & Scientific Affairs at Roka Bioscience... Read more

Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer

Basel, 10 April 2017 Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer Second Phase III head-to-head study that showed that Alecensa helped people with advanced ALK-positive non-small cell lung cancer (NSCLC) Results showed that people treated with Alecensa lived significantly longer without their disease progressing compared... Read more

PerkinElmer to Hold Earnings Call on Thursday, May 4, 2017

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that on Thursday, May 4, 2017, after market close, the Company will release first quarter 2017 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert... Read more

Seven Bridges Announces Strategic Partnership With Spatial Transcriptomics

Relationship Aims to Advance Development of Innovative Tools for Visualizing and Analyzing Gene Expression within Tissue Samples April 4, 2017 CAMBRIDGE, Mass., April 4, 2017 –Seven Bridges, the biomedical data analysis company, today announced an investment in Spatial Transcriptomics, a life sciences start-up developing innovative technology to analyze tissue samples and gene expression data in... Read more

Xylem increases its 2020 financial targets and reaffirms its strategy to reflect accelerated growth driven by acquisitions

Company also reaffirms full-year 2017 guidance RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 4, 2017– At its Investor Day in Raleigh-Durham, North Carolina, Xylem (NYSE:XYL), a leading global water technology company, today will update its 2020 financial guidance and showcase the broad portfolio of smart infrastructure technologies and solutions provided by its Sensus and Visenti businesses. Xylem acquired... Read more

Xylem to host its 2017 Investor and Analyst Day

RYE BROOK, N.Y.–(BUSINESS WIRE)–Mar. 31, 2017– Xylem Inc. (NYSE: XYL), a leading global water technology company focused on addressing the world’s most challenging water issues, will host its 2017 Investor and Analyst Day on Tuesday, April 4, in Raleigh Durham, N.C. Xylem President and Chief Executive Officer Patrick Decker, along with key members of his... Read more